Guangdong Hybribio Biotech Co.,Ltd. (SHE:300639)
6.14
+0.24 (4.07%)
Sep 21, 2026, 3:04 PM CST
SHE:300639 Market Cap
SHE:300639 has a market cap or net worth of 3.85 billion as of September 21, 2026. Its market cap has increased by 7.34% in one year.
Market Cap
3.85B
Enterprise Value
2.97B
Revenue
654.72M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.14
ChartMarket Cap Chart
Since April 12, 2017, SHE:300639's market cap has increased from 2.38B to 3.85B, an increase of 61.70%. That is a compound annual growth rate of 5.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 21, 2026 | 3.85B | 14.13% |
| Dec 31, 2025 | 3.38B | -10.48% |
| Dec 31, 2024 | 3.77B | -37.03% |
| Dec 29, 2023 | 5.99B | -18.63% |
| Dec 30, 2022 | 7.36B | -14.35% |
| Dec 31, 2021 | 8.59B | -2.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 12, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Amoy Diagnostics | 7.16B |
| Beijing Strong Biotechnologies,Inc. | 6.85B |
| Shanghai Runda Medical Technology | 6.11B |
| Cowealth Medical China | 5.56B |
| Maccura Biotechnology Co.Ltd | 5.49B |
| Shanghai Labway Clinical Laboratory | 4.71B |
| Medicalsystem Biotechnology | 3.80B |
| Thalys Medical Technology Group | 3.59B |